These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14844779)

  • 1. [Experimental in vitro research on the effect of chloromycetin on vaccinia aphthous fever, and field rabies viruses].
    RAVAIOLI L; NEGRI R
    Rend Ist Sup Sanit; 1950; 13(6-8):546-54. PubMed ID: 14844779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trials with 2,4-dichlorophenoxyacetic acid (2,4-D) on fixed rabies, poliomyelitis, vaccinia and western equine encephalitis viruses in vitro and in vivo].
    GARCIA-GANCEDO AP; ALONSO L; GALLARDO E
    Microbiol Esp; 1960; 13():31-47. PubMed ID: 13826463
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental therapy of rabies and vaccinia encephalitis in rabbits].
    UCHITEL' IIa
    Vopr Virusol; 1958; 3(3):172-3. PubMed ID: 13569998
    [No Abstract]   [Full Text] [Related]  

  • 4. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 5. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo inhibition by beta-phenylserine of rabies, myxoma, and vaccinia viruses.
    PONS MW; PRESTON WS
    Virology; 1961 Oct; 15():164-72. PubMed ID: 14487799
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of a baiting system for vaccinating foxes against rabies with vaccinia-rabies recombinant virus.
    Brochier BM; Languet B; Artois M; Zanker S; Guittre C; Blancou J; Chappuis G; Desmettre P; Pastoret PP
    Vet Rec; 1990 Aug; 127(7):165-7. PubMed ID: 2219648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
    Li P; Hu Q; Sun Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the interference between vaccinal virus and rabies virus].
    Vieuchange J
    Bull Acad Natl Med; 1968 Apr; 152(13):234-7. PubMed ID: 4913496
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat].
    Blancou J; Artois M; Brochier B; Thomas I; Pastoret PP; Desmettre P; Languet B; Kiény MP
    Ann Rech Vet; 1989; 20(2):195-204. PubMed ID: 2751231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of recombinant vaccinia-rabies vaccine in veterinary use.
    Pastoret PP; Brochier B; Languet B; Duret C; Chappuis G; Desmettre P
    Dev Biol Stand; 1996; 87():245-9. PubMed ID: 8854024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabies. Immunization in the field.
    Anderson RM
    Nature; 1991 Dec 19-26; 354(6354):502-3. PubMed ID: 1758491
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with antirabies vaccination of foxes using the oral route coordinated among several European countries and perspectives on the use of recombinant vaccinia-rabies virus].
    Pastoret PP; Blancou J; Brochier B; Thomas I; Paquot A; Debruyn J; Costy F; Wolff F; Kieny MP; Languet B
    Parassitologia; 1988; 30(1):149-54. PubMed ID: 3268767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trends in research in developing new type of vaccines--aiming at efficacy and safety. Rabies vaccine].
    Mifune K; Mannen K; Kawano H
    Nihon Rinsho; 1987 Oct; 45(10):2397-402. PubMed ID: 3448274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of chloromycetin in experimental rabies. Note II].
    POLI M
    Boll Soc Ital Biol Sper; 1950 Jun; 26(6):889-91. PubMed ID: 14801243
    [No Abstract]   [Full Text] [Related]  

  • 16. Human infection due to recombinant vaccinia-rabies glycoprotein virus.
    Rupprecht CE; Blass L; Smith K; Orciari LA; Niezgoda M; Whitfield SG; Gibbons RV; Guerra M; Hanlon CA
    N Engl J Med; 2001 Aug; 345(8):582-6. PubMed ID: 11529212
    [No Abstract]   [Full Text] [Related]  

  • 17. How do vaccinia-vectored vaccines fit into animal immunization programmes?
    Brown F
    Res Virol; 1989; 140(5):474-6. PubMed ID: 2685957
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route.
    Thomas I; Brochier B; Languet B; Blancou J; Peharpre D; Kieny MP; Desmettre P; Chappuis G; Pastoret PP
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():37-42. PubMed ID: 2406370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(43):1204-7. PubMed ID: 19893480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.